New Italian Rules Ease The Way To Personal Import Of Cheaper Medicines
A circular issued by the Italian health ministry has relaxed the rules on the personal import of medicines that are approved elsewhere but not in Italy, and extended the mechanism to products that are approved in Italy but inaccessible to certain patients for eligibility or cost reasons.
You may also be interested in...
New medicines for hepatitis C and cancer are among innovative therapies benefiting from two special funds set up by the Italian government.
Companies marketing dexamethasone in Europe have been told they can use a CHMP endorsement to request the addition of COVID-19 to their product license.
A “powerful new vision” for the post-Brexit UK regulatory framework was unveiled at a conference organized by the BioIndustry Association and the medicines regulator, the MHRA.